Baba, Vevencio, JR.. S.
HRN: 14-66-82 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/01/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/02/2023
06/08/2023
IVTT
2.25 G
Q6
CapHR; (antibiotic Extension)
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes